Evidence map›Paper›PMID 39211109›Full record

ArticlebioRxiv : the preprint server for biology2024

Dose-dependent regulation of immune memory responses against HIV by saponin monophosphoryl lipid A nanoparticle adjuvant.

Parham Ramezani-Rad, Ester Marina-Zárate, Laura Maiorino, Amber Myers, Katarzyna Kaczmarek Michaels, Ivan S Pires, Nathaniel I Bloom, Paul G Lopez, Christopher A Cottrell, Iszac Burton and 16 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Parham Ramezani-Rad
Ester Marina-Zárate
Laura Maiorino
Amber Myers
Katarzyna Kaczmarek Michaels
Ivan S Pires
Nathaniel I Bloom
Paul G Lopez
Christopher A CottrellORCID 0000-0002-3364-3083
Iszac Burton
Bettina Groschel
Arpan Pradhan
Gabriela Stiegler
Magdolna Budai
Daniel Kumar
Sam Pallerla
Eddy Sayeed
Sangeetha L Sagar
Sudhir Pai Kasturi
Koen K A Van Rompay
Lars Hangartner
Andreas Wagner
Dennis R Burton
William R Schief
Darrell J Irvine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The induction of durable protective immune responses is the main goal of prophylactic vaccines, and adjuvants play an important role as drivers of such responses. Despite advances in vaccine strategies, a safe and effective HIV vaccine remains a significant challenge. The use of an appropriate adjuvant is crucial to the success of HIV vaccines. Here we assessed the saponin/MPLA nanoparticle (SMNP) adjuvant with an HIV envelope (Env) trimer, evaluating the safety and impact of multiple variables including adjuvant dose (16-fold dose range), immunization route, and adjuvant composition on the establishment of Env-specific memory T and B cell responses (T

Identifiers

PMID39211109
PMCPMC11361155

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.